FindTrial
Sign In

Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1

Long non-coding RNA EPB41L4A-AS2 suppresses progression of ovarian cancer by sequestering microRNA-103a to upregulate transcription factor RUNX1T1

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900025687
Enrollment
Unknown
Registered
2019-09-05
Start date
2012-02-03
Completion date
Unknown
Last updated
2019-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ovarian cancer

Interventions

Ovarian Cancer Tissue
Paracancerous tissue :NA

Sponsors

Jining First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients who underwent resection for ovarian cancer in our hospital

Exclusion criteria

Exclusion criteria: All patients had anti-tumor treatment such as radiotherapy or chemotherapy before operation.

Design outcomes

Primary

MeasureTime frame
EPB41L4A-AS2 mRNA expression;—

Countries

China

Contacts

Public ContactYunbin Gao

Jining First People's Hospital

gaoyunbin8@yeah.net+86 0537 2255809

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026